127 related articles for article (PubMed ID: 10666682)
1. Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.
Greber-Platzer S; Schatzmann-Turhani D; Cairns N; Balcz B; Lubec G
J Neural Transm Suppl; 1999; 57():269-81. PubMed ID: 10666682
[TBL] [Abstract][Full Text] [Related]
2. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.
Wolvetang EJ; Bradfield OM; Hatzistavrou T; Crack PJ; Busciglio J; Kola I; Hertzog PJ
Neurobiol Dis; 2003 Dec; 14(3):349-56. PubMed ID: 14678752
[TBL] [Abstract][Full Text] [Related]
4. The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.
Wolvetang EW; Bradfield OM; Tymms M; Zavarsek S; Hatzistavrou T; Kola I; Hertzog PJ
Biochim Biophys Acta; 2003 Jul; 1628(2):105-10. PubMed ID: 12890557
[TBL] [Abstract][Full Text] [Related]
5. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
[TBL] [Abstract][Full Text] [Related]
6. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.
Wolvetang EJ; Wilson TJ; Sanij E; Busciglio J; Hatzistavrou T; Seth A; Hertzog PJ; Kola I
Hum Mol Genet; 2003 Feb; 12(3):247-55. PubMed ID: 12554679
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect.
Engidawork E; Baiic N; Fountoulakis M; Dierssen M; Greber-Platzer S; Lubec G
J Neural Transm Suppl; 2001; (61):335-46. PubMed ID: 11771756
[TBL] [Abstract][Full Text] [Related]
8. Determination of the protooncogene ets-2 gene transcript in human brain at the atto-gram-level by the use of competitive RT/PCR.
Schatzmann-Turhani D; Greber-Platzer S; Cairns N; Lubec G
Amino Acids; 1999; 16(1):13-9. PubMed ID: 10078330
[TBL] [Abstract][Full Text] [Related]
9. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.
Baldus CD; Liyanarachchi S; Mrózek K; Auer H; Tanner SM; Guimond M; Ruppert AS; Mohamed N; Davuluri RV; Caligiuri MA; Bloomfield CD; de la Chapelle A
Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3915-20. PubMed ID: 15007164
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ETS2 in human esophageal squamous cell carcinoma.
Li X; Lu JY; Zhao LQ; Wang XQ; Liu GL; Liu Z; Zhou CN; Wu M; Liu ZH
World J Gastroenterol; 2003 Feb; 9(2):205-8. PubMed ID: 12532432
[TBL] [Abstract][Full Text] [Related]
12. ETS family of genes in leukemia and Down syndrome.
Papas TS; Watson DK; Sacchi N; Fujiwara S; Seth AK; Fisher RJ; Bhat NK; Mavrothalassitis G; Koizumi S; Jorcyk CL
Am J Med Genet Suppl; 1990; 7():251-61. PubMed ID: 2149958
[TBL] [Abstract][Full Text] [Related]
13. c-fos expression in brains of patients with Down syndrome.
Greber-Platzer S; Balcz B; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():75-85. PubMed ID: 10666669
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.
Carbone GM; McGuffie EM; Collier A; Catapano CV
Nucleic Acids Res; 2003 Feb; 31(3):833-43. PubMed ID: 12560478
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the chromosome 21 transcription factor Ets2 in cell-seeded three-dimensional bone constructs.
Turhani D; Watzinger E; Weissenböck M; Yerit K; Cvikl B; Ewers R; Thurnher D
J Biomed Mater Res A; 2005 Jun; 73(4):445-55. PubMed ID: 15900611
[TBL] [Abstract][Full Text] [Related]
16. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
17. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
18. Defective trophoblast function in mice with a targeted mutation of Ets2.
Yamamoto H; Flannery ML; Kupriyanov S; Pearce J; McKercher SR; Henkel GW; Maki RA; Werb Z; Oshima RG
Genes Dev; 1998 May; 12(9):1315-26. PubMed ID: 9573048
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.
Bhat NK; Thompson CB; Lindsten T; June CH; Fujiwara S; Koizumi S; Fisher RJ; Papas TS
Proc Natl Acad Sci U S A; 1990 May; 87(10):3723-7. PubMed ID: 2187191
[TBL] [Abstract][Full Text] [Related]
20. ETS2 is involved in protein kinase C-activated expression of granulocyte-macrophage colony-stimulating factor in human non-small lung carcinoma cell line, A549.
Lu Z; Kim KA; Suico MA; Uto A; Seki Y; Shuto T; Isohama Y; Miyata T; Kai H
Biochem Biophys Res Commun; 2003 Mar; 303(1):190-5. PubMed ID: 12646185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
